Stephen J O'Brien1, Jacob Hallion1, Katharina M Scheurlen1, Casey Fiechter1, James Burton1, Mason Paas1, Miranda Schmidt1, Sarah Gardner1, Maurice R Eichenberger1, Jianmin Pan2, Shesh Rai2, Susan Galandiuk3. 1. Price Institute of Surgical Research, The Hiram C. Polk Jr. MD Department of Surgery, University of Louisville School of Medicine, 550 South Jackson Street, Louisville, KY, 40202, USA. 2. Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA. 3. Price Institute of Surgical Research, The Hiram C. Polk Jr. MD Department of Surgery, University of Louisville School of Medicine, 550 South Jackson Street, Louisville, KY, 40202, USA. susan.galandiuk@louisville.edu.
Abstract
BACKGROUND: Ileal pouch-anal anastomosis (IPAA) is a common surgical treatment for ulcerative colitis. Afferent limb stenosis is an infrequent complication following IPAA, suggesting underlying Crohn's disease (CD). We hypothesized that CD-related single nucleotide polymorphisms (SNPs) are associated with afferent limb stenosis. METHODS: Afferent limb stenosis and CD control group patients were recruited from a prospective institutional inflammatory bowel disease database and associated biobank. Patient demographics, Montreal classification, and medication use were recorded. Ten SNPs associated with stricturing Crohn's disease were examined in genomic DNA and compared among afferent limb stenosis, stricturing CD, and non-stricturing CD controls. RESULTS: Twenty-seven afferent limb stenosis and 162 CD control group patients (108 stricturing, 54 non-stricturing) were identified. Patients were gender and race matched. Afferent limb stenosis and stricturing CD controls were younger at diagnosis (Montreal A1/A2 vs. A3) compared to non-stricturing CD controls (both p < 0.05). The majority of afferent limb stenosis patients were non-smokers compared to CD controls (74% vs. 36%, p < 0.01) and did not use biologic therapies (4% vs. 37%, p < 0.001). The FUT2 G allele was more frequent in afferent limb stenosis and stricturing CD controls compared to non-stricturing CD controls (both p < 0.05). The NOD2 T allele was more frequent in stricturing CD controls compared to afferent limb stenosis and non-stricturing CD controls (both p < 0.05). CONCLUSION: Afferent limb stenosis patients are phenotypically similar to stricturing CD controls, but differ with lower smoking rates and lower NOD2 allele frequency. Such differences could contribute to the presentation delay with a stricturing phenotype. Selective SNP assessment may help categorize patients likely to develop afferent limb stenosis.
BACKGROUND: Ileal pouch-anal anastomosis (IPAA) is a common surgical treatment for ulcerative colitis. Afferent limb stenosis is an infrequent complication following IPAA, suggesting underlying Crohn's disease (CD). We hypothesized that CD-related single nucleotide polymorphisms (SNPs) are associated with afferent limb stenosis. METHODS: Afferent limb stenosis and CD control group patients were recruited from a prospective institutional inflammatory bowel disease database and associated biobank. Patient demographics, Montreal classification, and medication use were recorded. Ten SNPs associated with stricturing Crohn's disease were examined in genomic DNA and compared among afferent limb stenosis, stricturing CD, and non-stricturing CD controls. RESULTS: Twenty-seven afferent limb stenosis and 162 CD control group patients (108 stricturing, 54 non-stricturing) were identified. Patients were gender and race matched. Afferent limb stenosis and stricturing CD controls were younger at diagnosis (Montreal A1/A2 vs. A3) compared to non-stricturing CD controls (both p < 0.05). The majority of afferent limb stenosispatients were non-smokers compared to CD controls (74% vs. 36%, p < 0.01) and did not use biologic therapies (4% vs. 37%, p < 0.001). The FUT2 G allele was more frequent in afferent limb stenosis and stricturing CD controls compared to non-stricturing CD controls (both p < 0.05). The NOD2 T allele was more frequent in stricturing CD controls compared to afferent limb stenosis and non-stricturing CD controls (both p < 0.05). CONCLUSION: Afferent limb stenosispatients are phenotypically similar to stricturing CD controls, but differ with lower smoking rates and lower NOD2 allele frequency. Such differences could contribute to the presentation delay with a stricturing phenotype. Selective SNP assessment may help categorize patients likely to develop afferent limb stenosis.
Authors: Willem E Hueting; Erik Buskens; Ingeborg van der Tweel; Hein G Gooszen; Cees J H M van Laarhoven Journal: Dig Surg Date: 2005-04-14 Impact factor: 2.588
Authors: Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin Journal: Ann Surg Date: 2013-04 Impact factor: 12.969
Authors: J Landy; H O Al-Hassi; S D McLaughlin; S C Knight; P J Ciclitira; R J Nicholls; S K Clark; A L Hart Journal: Inflamm Bowel Dis Date: 2011-10-21 Impact factor: 5.325
Authors: Amy L Lightner; Kellie L Mathis; Eric J Dozois; Dieter Hahnsloser; Edward V Loftus; Laura E Raffals; John H Pemberton Journal: Inflamm Bowel Dis Date: 2017-05 Impact factor: 5.325
Authors: Bo Shen; Victor W Fazio; Feza H Remzi; Conor P Delaney; Jean-Paul Achkar; Anna Bennett; Farah Khandwala; Aaron Brzezinski; Jhony Doumit; Wendy Liu; Bret A Lashner Journal: Am J Gastroenterol Date: 2004-12 Impact factor: 10.864
Authors: Peter L Lakatos; Zsuzsanna Vegh; Barbara D Lovasz; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Istvan Szita; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Petra A Golovics; Michael Mandel; Agnes Horvath; Miklos Szathmari; Lajos S Kiss; Laszlo Lakatos Journal: Inflamm Bowel Dis Date: 2013-04 Impact factor: 5.325
Authors: Genevieve B Melton; Victor W Fazio; Ravi P Kiran; Jin He; Ian C Lavery; Bo Shen; Jean-Paul Achkar; James M Church; Feza H Remzi Journal: Ann Surg Date: 2008-10 Impact factor: 12.969
Authors: Isabelle Cleynen; Juan R González; Carolina Figueroa; Andre Franke; Dermot McGovern; Martin Bortlík; Bart J A Crusius; Maurizio Vecchi; Marta Artieda; Magdalena Szczypiorska; Johannes Bethge; David Arteta; Edgar Ayala; Silvio Danese; Ruud A van Hogezand; Julian Panés; Salvador Amado Peña; Milan Lukas; Derek P Jewell; Stefan Schreiber; Severine Vermeire; Miquel Sans Journal: Gut Date: 2012-12-21 Impact factor: 23.059
Authors: Uri Netz; Jane Victoria Carter; Maurice Robert Eichenberger; Gerald Wayne Dryden; Jianmin Pan; Shesh Nath Rai; Susan Galandiuk Journal: World J Gastroenterol Date: 2017-07-21 Impact factor: 5.742